The rapid advance of the field of genomics over the past decade has revolutionised understanding of the causes of rare and common heritable diseases, cancers and even infectious diseases. It has been a dream in clinical medicine to be able to identify those at highest risk of disease to target for preventative medicines, and to be able to tailor medicines to individuals based on their likelihood of response and risk of side effects. Genomics approaches entering clinical practice right now are bringing these dreams to reality.
ABOUT THE SPEAKER
Professor Matt Brown is a clinician-scientist who trained initially as a rheumatologist before heading off into a career in immunogenetics research, initially at the University of Oxford, then between 2005-2016 at University of Queensland. His particular interest is in the disease ankylosing spondylitis, where he has played a major role dissecting the genetic causes of the disease and developing new treatments for it. He is also deeply interested in the translation of genomics into clinical applications, including in common and rare heritable diseases, and cancers. Matt was Director of the University of Queensland, Diamantina Institute from 2011 until 2015. He is a Fellow of both the Australian Academy of Sciences and the Australian Academy of Health and Medical Sciences. In 2016, Matt transitioned to Queensland University of Technology as Director of Genomics where he aims to enhance the University’s genomics capabilities and continue his research with many new opportunities on the horizon both in Australia and internationally.
The live stream will be shown at https://www.qut.edu.au/live-streaming?stream=ifegrandchallenge.